Timber Creek Capital Management LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 21.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 9,655 shares of the healthcare conglomerate's stock after selling 2,577 shares during the period. UnitedHealth Group makes up 1.3% of Timber Creek Capital Management LLC's holdings, making the stock its 26th biggest holding. Timber Creek Capital Management LLC's holdings in UnitedHealth Group were worth $5,057,000 as of its most recent filing with the SEC.
Other hedge funds also recently modified their holdings of the company. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in UnitedHealth Group in the fourth quarter valued at about $26,000. Hurley Capital LLC bought a new position in UnitedHealth Group in the fourth quarter valued at about $28,000. Aster Capital Management DIFC Ltd bought a new position in UnitedHealth Group in the fourth quarter valued at about $30,000. Finally, Promus Capital LLC bought a new position in UnitedHealth Group in the fourth quarter valued at about $32,000. Institutional investors own 87.86% of the company's stock.
Analysts Set New Price Targets
A number of research firms have issued reports on UNH. Barclays decreased their target price on UnitedHealth Group to $350.00 and set an "overweight" rating on the stock in a research report on Monday, June 2nd. JPMorgan Chase & Co. boosted their price target on UnitedHealth Group from $405.00 to $418.00 and gave the stock an "overweight" rating in a report on Friday, June 20th. Wall Street Zen cut UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Royal Bank Of Canada reduced their price target on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. Finally, Mizuho reduced their price target on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. One analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have given a buy rating to the company's stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and a consensus target price of $415.57.
Read Our Latest Stock Analysis on UnitedHealth Group
Insider Buying and Selling
In other news, CEO Stephen J. Hemsley acquired 86,700 shares of the company's stock in a transaction that occurred on Friday, May 16th. The shares were bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the purchase, the chief executive officer directly owned 679,493 shares in the company, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Timothy Patrick Flynn bought 1,533 shares of the company's stock in a transaction on Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the transaction, the director directly owned 6,033 shares in the company, valued at approximately $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 109,408 shares of company stock valued at $31,607,768 over the last 90 days. 0.28% of the stock is owned by insiders.
UnitedHealth Group Stock Performance
NYSE:UNH traded up $1.13 during mid-day trading on Friday, hitting $308.69. 6,161,145 shares of the company traded hands, compared to its average volume of 7,543,771. The firm has a market cap of $280.03 billion, a price-to-earnings ratio of 12.93, a price-to-earnings-growth ratio of 1.48 and a beta of 0.45. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock's fifty day moving average price is $324.99 and its 200-day moving average price is $447.68. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The firm had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. During the same quarter in the prior year, the firm posted $6.91 earnings per share. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were paid a dividend of $2.21 per share. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.86%. UnitedHealth Group's dividend payout ratio is currently 37.02%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.